Translational repression and deadenylation of eukaryotic mRNAs result either in the sequestration of the transcripts in a nontranslatable pool or in their degradation. Removal of the 5 0 cap structure is a crucial step that commits deadenylated mRNAs to 5 0 -to-3 0 degradation. Pat1, Edc3 and the DEAD-box protein Dhh1 are evolutionary conserved factors known to participate in both translational repression and decapping, but their interplay is currently unclear. We report the 2.8 Å resolution structure of yeast Dhh1 bound to the N-terminal domain of Pat1. The structure shows how Pat1 wraps around the Cterminal RecA domain of Dhh1, docking onto the Phe-Asp-Phe (FDF) binding site. The FDF-binding site of Dhh1 also recognizes Edc3, revealing why the binding of Pat1 and Edc3 on Dhh1 are mutually exclusive events. Using co-immunoprecipitation assays and structure-based mutants, we demonstrate that the mode of Dhh1-Pat1 recognition is conserved in humans. Pat1 and Edc3 also interfere and compete with the RNA-binding properties of Dhh1. Mapping the RNA-binding sites on Dhh1 with a crosslinking-mass spectrometry approach shows a large RNA-binding surface around the C-terminal RecA domain, including the FDF-binding pocket. The results suggest a model for how Dhh1-containing messenger ribonucleoprotein particles might be remodeled upon Pat1 and Edc3 binding.
INTRODUCTION
The fate of eukaryotic mRNAs is linked to the complement of proteins with which they associate to form messenger ribonucleoprotein particles (mRNPs) (1) . The 5 0 cap structure and the 3 0 poly(A) tail are general hallmarks of mRNPs that are targeted, either directly or indirectly, by translation factors as well as mRNA decay factors. Translation and decay are mutually dependent and antagonistic processes. The presence of the m 7 G cap structure at the 5 0 end, for example, is crucial for eIF4E binding and for translation initiation [reviewed in (2) ]. Conversely, its removal by the decapping complex is a prerequisite for 5 0 -3 0 degradation by the exoribonuclease Xrn1 [reviewed in (3) ]. Shortening of the poly(A)-tail is also linked to the shift of mRNA from active translation to a translationally repressed state in which the transcript can either be temporarily stored or can be decapped and degraded [reviewed in (4) ].
Although the exact sequence of events and interplay of the factors involved in translational repression, deadenylation and decay is currently debated, it is clear that removal of the cap structure is an irreversible step that commits the mRNA to 5 0 -3 0 degradation [reviewed in (3) ]. Studies originally in yeast have shown that decapping is catalyzed by Dcp1-Dcp2 (5, 6) and is activated in vivo by a cohort of regulators, including Pat1, Edc3, Scd6, Dhh1 and the heptameric Lsm 1-7 complex (7) (8) (9) (10) (11) (12) . These core components of the decapping machinery are conserved from yeast to humans, suggesting the presence of common basic mechanisms (13) . Additional components as well as detailed intermolecular interactions can, however, vary across species. All components of the decapping/5 0 -3 0 decay pathway co-localize in P-bodies together with factors involved in translational repression [reviewed in (14) (15) (16) (17) ]. Two P-body components in particular, Dhh1 and Pat1 (18) (19) (20) (21) (22) (23) (24) , appear to be at the intersection of translational repression and mRNA turnover [reviewed in (25, 26) ].
Pat1 is a conserved multidomain protein that forms a scaffold for protein-protein interactions: the N-terminal domain (NTD) binds Dhh1, the downstream region is important for P-body formation and the middle and C-terminal domains recruit a plethora of factors, including the decapping complex Dcp1-Dcp2, the Ccr4-Not complex, the Lsm1-7 complex and Xrn1 (22) (23) (24) 27) . The Ccr4-Not complex is a major deadenylase: it trims the mRNA 3 0 end to a short oligoadenylated tail that forms the platform for the Lsm1-7 complex [reviewed in (28) ]. Mechanistically, Pat1 is thus believed to link the deadenylated 3 0 end with the decapping factors at the 5 0 end. Indeed, Pat1 triggers deadenylation when tethered to mRNAs in human and Drosophila cells (22, 24) and leads to a strong effect in decapping upon deletion in yeast (8, 9) . In addition to its prevalent role in mRNA degradation, in yeast Pat1 acts as a translational repressor together with Dhh1 (18) .
Dhh1 (also known as RCK/p54/DDX6 in humans, Me31b in Drosophila melanogaster and CGH-1 in Caenorhabditis elegans) has been known as a decapping activator since the finding 10 years ago that its deletion in Saccharomyces cerevisiae stabilizes mRNA transcripts and inhibits decapping in vivo (10, 11) . However, Dhh1 does not appear to function like Pat1 and Edc3/Sdc6 by directly binding and activating the Dcp1-Dcp2 decapping complex (27, 29) . Evidence is instead accumulating pointing to a prevalent role of Dhh1 in translational repression in yeast (18, 30) as well as in higher eukaryotes (21, (31) (32) (33) (34) (35) . Dhh1 is highly abundant in all species examined to date [yeast (36) , Trypanosoma (37), Xenopus oocytes (38) and mammalian cells (39) ] and is present in large excess over the expected mRNA substrates (39, (40) (41) (42) . Dhh1 belongs to the DEAD-box protein family of RNA-dependent ATPases, but has several unusual features. While other DEAD-box proteins bind RNA and ATP in a cooperative manner (43) , Dhh1 binds RNA even in the absence of ATP (39, 44) . In addition, the two RecA-like domains of Dhh1 are not flexible as in most other DEAD-box proteins, but are engaged in intramolecular interactions (45) . This conformational rigidity restricts the ATPase activity of Dhh1 in vitro (44, 45) . In vivo, the ATPase activity of yeast Dhh1 is nonetheless critical for the dissociation from P-bodies (44, 46) . Dhh1 and Pat1 are emerging as crucial players in guiding the mRNPs from a translationally repressed state to a decapping state. The C-terminal RecA-like domain (RecA2) of Dhh1 is sufficient for translational repression and accumulation in P-bodies in human cells (21) . Studies with the Drosophila orthologues have shown that this domain of Dhh1 binds in a mutually exclusive manner Edc3 and Scd6 (known as TraI in flies) (47) , two partially redundant proteins with a similar domain organization (12) . The C-terminal RecA-like domain is also required to bind Pat1 (22) . In this work, we have elucidated the evolutionary conserved molecular mechanisms of the interaction between Dhh1 and Pat1, showing how Pat1 and Edc3 compete for the same surface of Dhh1 and how they impact on RNA binding. These results suggest that Dhh1 might switch protein and RNA-binding partners in the transition from translational repression to decapping.
MATERIALS AND METHODS

Protein expression and purification
S. cerevisiae Dhh1 and Dhh1 were cloned as Tobacco etc virus (TEV)-cleavable His 6 -GST-tag fusion proteins. They were expressed in BL21-Gold (DE3) pLysS (Stratagene) in Terrific Broth medium. Cells were resuspended in lysis buffer (20 mM Tris, pH 7.4, 200 mM NaCl) supplemented with 10 mM imidazole, DNase, lysozyme and phenylmethylsulfonyl fluoride, and lysed by sonication. Proteins (wild type and mutants) were purified using Nickel-based affinity chromatography. Point mutations were introduced by QuickChange sitedirected mutagenesis according to the manufacturer's instruction (Stratagene). The His 6 -GST tag was either kept or cleaved by overnight incubation with TEV. Proteins were further purified by ion exchange chromatography at pH 7.4 (Heparin, GE healthcare) followed by size-exclusion chromatography (Superdex 75, GE Healthcare).
S. cerevisiae Pat1 1-30 , Pat1 1-56 , Pat1 1-114 and Pat1 5-79 proteins were expressed as TEV-cleavable GST-Histagged proteins in BL21-Gold (DE3) pLysS cells. The cells were resuspended in lysis buffer and disrupted by sonication. The proteins were purified by Nickel-based affinity chromatography and then subjected (either tagged or untagged following the addition of TEV protease) to ion exchange chromatography at pH 8.0 (MonoQ 5/50, GE healthcare) and to size exclusion chromatography (Superdex 75). For isothermal titration calorimetry (ITC), Pat1 proteins were subcloned with a His 6 -SUMO tag. S. cerevisiae Edc3 77-158 was subcloned with His 6 -GST tag, while Edc3 77-158 and Edc3 77-116 were subcloned as cleavable His 6 -SUMO proteins. All proteins were expressed and purified following similar protocols as the ones described above. For crystallization, the His 6 -SUMO tag was cleaved using the SUMO protease Senp2.
The complexes of yeast Dhh1 with Pat1 or Edc3 were reconstituted by incubating the individually purified proteins in a 1:1.5 molar ratio for 1 h at 4 C. Dhh1-Pat1 and Dhh1-Edc3 were further purified by size exclusion chromatography (Superdex 75) in a buffer containing 20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM DTT.
Crystallization and structure determination
Crystallization was carried out at 18 C using the vapor diffusion method by mixing equal volumes of protein complex at 27 mg/ml and of crystallization buffer. The best diffracting crystals of Dhh1 All diffraction data were collected at 100 K at the beamline PXII of the Swiss Light Source synchrotron and processed using XDS. The structures were determined by molecular replacement with the program Phaser (48) using the two RecA domains from the apo Dhh1 structure (45) as search models. The atomic model was built with the program Coot (49) and refined with PHENIX (50) . The data collection and refinement statistics are summarized in Table 1 .
In vitro pull-down assays
Experiments were performed by mixing 3 mg of GSTtagged (bait) protein with equal molar amounts of untagged (prey) protein. Binding buffer (20 mM Hepes, pH 7.5, 250 mM NaCl, 2 mM MgAc 2 , 10% glycerol, 2 mM imidazole, 1 mM DTT, 0.1 % Nonidet 40) was added to a final volume of 60 ml. The reaction mixtures were incubated on ice for 1-2 h. Fifteen microliters of 50% (v/v) suspension of GSH-Sepharose beads in 200 ml of binding buffer was added to each reaction mixture and incubated at 4 C for 1 h. Beads were washed three times with 500 ml binding buffer. Bound proteins were eluted with 20 mM reduced glutathione. Samples were separated on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by Coomassie blue stain.
In vitro RNA-binding assays
The experiments were carried out essentially as previously described (52) . Single-stranded 5 0 biotinylated U 20 RNA (Dharmacon) was mixed with 3 mg of a given protein and/ or nucleotide in binding buffer (20 mM Hepes, pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, 10% glycerol, 0.1% Nonidet 40) to a final volume of 60 ml and was kept at 4 C overnight. Each reaction was then supplemented with 200 ml of binding buffer and 50 mg of preblocked magnetic streptavidin beads (Dynal) for 2 h, rocking at 4 C. Beads were washed three times with 500 ml of binding buffer. Proteins were eluted from the beads with 17 ml SDS loading buffer. Eluted samples were boiled for 5 min and analyzed on SDS-PAGE. 
Isothermal titration calorimetry
Co-immunoprecipitation assays
HEK293T cells were cultured in Dulbecco's modified Eagle medium containing 10% fetal bovine serum (Gibco), 100 U/ml penicillin and 0.1 mg/ml streptomycin (Gibco) at 37 C/5% CO 2 . Plasmids were transfected with Values in parentheses are for the highest-resolution shell.
polyethyleneimine (Polysciences Inc., 1 mg/ml) for protein interaction studies. HEK293T cells were collected from confluent 6-cm dish after 24 h of transient transfection. Cells were lysed in 300 ml of lysis buffer containing 10 mM Tris, pH 7.5, 10 mM NaCl, 10 mM EDTA, 0.5% Triton X-100 and protease inhibitors (Roche). Lysate was centrifuged at 1000g for 5 min at 4 C. Thirty microliters of GFP binder protein sepharose beads were added to supernatant for 1 h at 4 C. Beads were washed five times with 1 ml of NET2 buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Triton X-100) and proteins were eluted with 40 ml SDS sample buffer containing 5% b-mercaptoethanol. Eluted proteins were run on 12% polyacrylamide gels and transferred onto nitrocellulose membrane (0.45 mm pore size) (Whatman Protran BA85) for western blotting. Mouse monoclonal anti-GFP (Santa Cruz biotechnology, sc-9996) and anti-HA (Covance, MMS-101 R) antibodies and horseradish peroxidase-coupled goat antimouse (Millipore, AQ502A) secondary antibody were used in combination with ECL prime western blotting detection reagent (GE healthcare) for detection of HA-and GFP-tagged proteins via western blotting.
Crosslinking-mass spectrometry analysis
The protein-RNA contacts site on Dhh1 were investigated with mass spectrometry after UV-induced protein-RNA crosslinking as described in (53) . The purified crosslinks were analyzed using Top10HCD method on an Orbitrap Velos instrument and the data were analyzed using OpenMS and OMSSA as a search engine (see Supplementary Methods).
RESULTS AND DISCUSSION
Biochemical and biophysical characterization of the yeast Dhh1-Pat1 interaction S. cerevisiae Pat1 is an 88 kDa protein containing an NTD followed by a proline-rich region, a middle domain and a C-terminal domain (20, 22) (Figure 1A ). Dhh1 contains two RecA-like domains (RecA1 and RecA2) flanked by N-terminal and C-terminal low-complexity regions (45) ( Figure 1A ). The NTD of Pat1 is conserved from yeast to humans and has been shown in the case of the D. melanogaster and human proteins to mediate the interaction with the corresponding Dhh1 orthologues using co-immunoprecipitation assays (22, 23) . This domain is also part of a larger region found to strongly bind Dhh1 in the case of the yeast proteins (27) .
To investigate the S. cerevisiae Dhh1-Pat1 complex, we first narrowed down the interacting domains using pulldown assays with recombinant Dhh1 and GST-tagged Pat1 proteins. The NTD of yeast Pat1 (residues 1-114) efficiently precipitated the DEAD-box core of Dhh1 (residues 30-425, including RecA1 and RecA2) ( Figure 1B, lane 9) . A segment of the Pat1 NTD that we engineered based on evolutionary conservation (residues 1-56) was also able to precipitate Dhh1 (Figure 1B, lane 8) , while no binding was observed when using a fragment of Pat1 encompassing residues 1-30 ( Figure 1B, lane 7) . To experimentally identify a Pat1 segment suitable for structural studies, we purified the complex of Dhh1 and Pat1 1-114 and subjected it to limited proteolysis. Treatment with the protease chymotrypsin resulted in the accumulation of a fragment that we characterized using mass spectrometry analysis and N-terminal sequencing as corresponding to Pat1 residues 5-79 ( Figure 1C) .
Next, we assessed binding affinities quantitatively using ITC. In the presence of 150 mM salt, yeast Dhh1 30- Figure 1D , right panel). We concluded that the Dhh1-Pat1 interaction is confined to the RecA2 domain of the DEADbox protein.
Crystal structure determination of a yeast Dhh1-Pat1 complex
Attempts to crystallize yeast Pat1 or Pat1 with the RecA2 domain of Dhh1 failed, as the complexes appeared to be too soluble to achieve the supersaturated conditions required for nucleation. Complexes of Pat1 with Dhh1 30-425 yielded the same crystal form that was previously reported for apo-Dhh1 (45), and indeed contained only Dhh1. Inspection of this crystal form revealed that the RecA2 domain of a Dhh1 molecule contacts the RecA1 domain of a neighboring Dhh1 molecule in the lattice (Supplementary Figure S2A) . The surface of RecA2 mediating crystal contacts is conserved and has been shown in the case of the human orthologue DDX6 to bind the Phe-Asp-Phe (FDF) motif of Edc3 (35) .
We reasoned that lattice contacts might promote the dissociation of Pat1 from RecA2 during crystallization. We therefore mutated the corresponding interacting surface of the RecA1 domain (Supplementary Figure  S2) , which did not contribute to Pat1 binding as assessed by quantitative binding affinity measurements ( Figure 1D ). For crystallization purposes, we introduced the Lys234Asp, Val238Asp substitutions in Dhh1 46-422 , a construct that includes only the ordered polypeptide region observed in the structure of apo Dhh1 (45) . Dhh1 46-422 K234D, V238D and Pat1 5-79 crystallized as a complex and yielded crystals that diffracted to 2.8 Å resolution. The structure was determined by molecular replacement and refined to an R free of 24.7%, R work of 20.6% and good stereochemistry ( Table 1 Figure S2B) . The difference probably arises from the mutations we had introduced: an intramolecular interaction between the two RecA domains observed in the structure of the wild-type protein (a salt bridge between Lys234 and Glu251) is impaired by the K234D mutation (Supplementary Figure S2B ). In either conformation, the residues mutated on RecA1 are at >40 Å distance from the residues that bind Pat1 N (Figure 2 and Supplementary Figure S2B ). Pat1 N wraps around the RecA2 domain of Dhh1, burying 10% (9118 Å 2 ) of the solvent accessible surface. Pat1 N folds into an a-helical segment (residues 25-42) and an extended segment (residues 43-54) (Figure 2 ).
An extended segment of yeast Pat1 docks onto the FDF-binding site of Dhh1
The extended segment of yeast Pat1 N contains a FDF sequence motif (residues 51-53). The FDF motif binds at a shallow surface pocket on the RecA2 domain of yeast Dhh1 (that we refer to as the patch 1 surface) formed by Ala263, Val265, Cys273, Leu277 and Ile409 ( Figure 3A, central panel) . The motif is recognized at the same pocket and with the same conformation as the DDX6-bound FDF motif of human Edc3 (patch 1, Figure 3A , left panel) (35) . Mutation of four residues surrounding the FDF-binding site in D. melanogaster Me31b has been previously shown by co-immunoprecipitation studies to abolish Edc3 binding (35) . We mutated the equivalent residues at the patch 1 surface of yeast Dhh1 (Mut-1: Asn269Ala, His272Ala, Thr276Ala, Lys280Ala). In pull-down assays with purified GST-tagged Pat1 and Dhh1 proteins, the binding of Pat1 to Mut-1 was decreased as compared with wild-type Dhh1 ( Figure 3B, compare lanes 3 and 7) .
In the case of human Edc3, the FDF motif is followed by two helices that contain a conserved Phe-Asp-Lys FDK motif and bind at a second surface patch (35) (patch 2, Figure 3A , left panel). In the structure of yeast Pat1 N , there is no ordered extension C-terminal to the FDF motif ( Figure 3A , central panel), although this part of the molecule is in principle present in the construct we crystallized. We engineered a yeast Dhh1 mutant with substitutions at patch 2 (Mut-2: Phe393Ala, Tyr396Ala, Glu399Ala, Gln400Ala) corresponding to the Me31b mutant shown to abolish Edc3 binding in the case of the D. melanogaster proteins (35) . Consistently with the structure, yeast Pat1 5-79 was able to precipitate Mut-2 Dhh1 ( Figure 3B, lane 6) . As a control, we tested the Dhh1 mutants with yeast Edc3 77-158 . This 80-residue long segment of yeast Edc3 includes the equivalent 30-residue long segment of human Edc3 that is ordered in the structure with DDX6 (35) ( Figure 4A ). The Mut-1 and Mut-2 Dhh1 proteins failed to interact with yeast Edc3 (Figure 3C , compare lane 3 with lanes 7 and 6). These results indicated that yeast Pat1 and Edc3 compete for the same FDF-binding site on Dhh1 (patch 1). Yeast Pat1 N , however, lacks the additional Dhh1-binding segment at the C-terminus of the FDF motif (patch 2) that is present in human and Drosophila Edc3 (while absent in TraI) (35) . Figure 4A ). We therefore tested whether the hydrophobic residue in the DW motif of human Pat1b might dock on the FDFbinding pocket of DDX6. We transiently co-expressed full-length HA-tagged DDX6 and YFP-tagged Pat1b residues 1-84 (hereby referred to as YFP-Pat1b) in HEK293T cells and carried out co-immunoprecipitation assays with GFP-binder beads. We found that a Trp46Ala or a Trp46Asp substitution in YFP-Pat1b strongly decreased the interaction with full-length HA-tagged DDX6 ( Figure 4B ). The effect was similar to a Pat1-4A mutant that has been recently shown to impair Dhh1 binding (54) . In this assay, mutation of the FDF-binding site in human HA-tagged DDX6 (Mut-1) significantly decreased the interaction with YFP-Pat1b ( Figure 4C ). We concluded that the interaction of Pat1 at the FDFbinding site of Dhh1 is evolutionary conserved in yeast and humans. Drosophila HPat is also expected to dock at the FDF-binding site of Me31b (Figure 4A ), but it is possible that in this case the FDF-binding site contributes less to the overall interaction, explaining previous coimmunoprecipitation data (35) .
An acidic helical segment of Pat1 docks onto a positively charged surface of Dhh1 N-terminal to the FDF motif, Pat1 N features a helical segment that binds with extensive interactions at a third surface patch on Dhh1 (patch 3, Figure 3A , right panel). The helical segment of Pat1 is highly negatively charged ( Figure 4A ) and binds to a positively charged surface of Dhh1. Pat1 Asn34, Asn38, Thr41 and Asp45 make polar contacts with Dhh1 Ser292, Asn294 and Arg295 ( Figure 3A, right panel) . In addition, Pat1 Glu33 forms a salt bridge with Dhh1 Lys362 and Pat1 Phe42 makes hydrophobic contacts with Dhh1 Leu298, Phe358 and Arg295. The human Pat1b-4A mutant shown to disrupt the interaction with DDX6 (54) (Figure 4B ) maps to the helical segment of Pat1 (alanine substitutions at Asp34, Asp35, Thr36, Phe37, Figure 4A ). We engineered mutations in Dhh1 to disrupt patch 3. Substitutions of Ser292Asp, Asn294Asp (Mut-3A) or of Arg295Asp (Mut-3B) abolished binding to Pat1 in GST pull-down assays ( Figure 3B, lanes 4 and 5) . The interacting residues are conserved in the human orthologues. Indeed a combined mutation of the Mut-3A and Mut-3B substitutions in human DDX6 (Ser343Asp, Gln345Asp, Arg346Asp or Mut-3C) impaired the interaction with human Pat1 in co-immunoprecipitation assays ( Figure 4C) .
Comparison of the structure of Dhh1-Pat1 with that of the DEAD-box protein eIF4AIII in the exon junction complex (EJC) (55, 56) reveals that the patch 3 surface is used in both DEAD-box proteins to recruit binding partners (Supplementary Figure S3) . The EJC is an assembly formed by four proteins (eIF4AIII, Btz, Mago and Y14), RNA and ATP (57) . In the EJC, eIF4AIII binds RNA with the two RecA domains in the typical closed conformation observed in all known structures of DEAD-box proteins in the active (RNA-ATP-bound) state (55, 56) . Btz wraps around eIF4AIII and contributes to RNA binding. The N-terminal segment of Btz contacts RNA directly (via Phe188). In addition, Btz features several positively charged residues (Arg176, Arg184 and Arg185) that form a favorable electrostatic environment for an incoming nucleic acid (Supplementary Figure S3) . The helical segment of Pat1 N also approaches the RNA-binding site expected for the ATP-bound conformation, but features several surface-exposed negatively charged residues (Glu28, Glu30, Glu32, Asp35, Asp39 and Glu40) that are predicted to electrostatically disfavor binding of Dhh1 to nucleic acids (Supplementary Figure S3) .
Yeast Edc3 contains an acidic segment similar to Pat1
Originally as a control, we tested the Dhh1 patch 3 mutants with yeast Edc3 77-158 ( Figure 3C ). In the human DDX6-Edc3 structure (35) , there is no ordered segment N-terminal to the FDF motif of Edc3 and therefore there is no binding to the corresponding patch 3 surface of DDX6. In pull-down assays, however, yeast Edc3 77-158 failed to interact with the Mut-3A and Mut-3B Dhh1 proteins ( Figure 3C, lanes 4 and 5) . As we could not rationalize these biochemical results based on the available structural information, we set out to determine the crystal structure of yeast Dhh1-Edc3. Yeast Dhh1 interacted with Edc3 77-158 with a Kd of 200 nM (Supplementary Figure S1B) . The Edc3 77-158 construct is considerably longer than the boundaries (residues 98-127) expected from the structure of human Edc3 (35) . Initial crystals of the complex of yeast Dhh1 46-422 K234D, V238D and Edc3 77-158 diffracted to 3.5 Å resolution. The electron density map was of sufficient quality to show binding of yeast Edc3 to patch 3 and to narrow down the domain boundaries (i.e. no ordered electron density beyond residue 116 of Edc3) (data not shown). We proceeded to crystallize yeast Dhh1 K234D, V238D and Edc3 77-116 . The structure was determined at 3.25 Å resolution with an R free of 24.6% and Rfactor of 21.0%. The final model includes residues 46-420 of Dhh1 and residues 88-116 of yeast Edc3 ( Figure 5A ).
Comparison of the yeast Dhh1-Edc3 structure with that of human DDX6-Edc3 shows a similar binding of the FDF motif at the patch 1 surface. There is no equivalent binding of a C-terminal helix to patch 2 ( Figure 5A ). However, this is likely an artifact of crystallization, due to a crystal contact that blocks Edc3 from accessing patch 2 of Dhh1. Indeed, binding of Dhh1 to yeast Edc3 was abolished by the patch 2 mutations ( Figure 3C , lane 6). More importantly, yeast Edc3 features an ordered segment (residues 88-104) N-terminal to the FDF motif ( Figure 5A ). In this segment, Trp91 of yeast Edc3 binds in the same pocket of patch 3 as Phe42 of yeast Pat1, explaining the results of the pull-down assays with the patch 3 mutants ( Figure 3C ). Also similarly to yeast Pat1, this segment of Edc3 is rich in negatively charged residues ( Figure 5B ). While the N-terminal segment of Pat1 N is evolutionary conserved, the N-terminal segment of yeast Edc3 is apparently not present in the human and Drosophila orthologues. Indeed, the Mut-3C substitutions in human DDX6 did not impair the interaction with human Edc3 in co-immunoprecipitation assays ( Figure 5C ). We concluded that these differences in the structures of the orthologous complexes reflect genuine differences in the interactions.
Pat1 and Edc3 disrupt RNA binding of Dhh1
We tested the effect of yeast Pat1 and Edc3 on the RNAbinding properties of Dhh1 using a biotin-RNA pull-down assay. In agreement with previous findings, Dhh1 was precipitated by biotinylated RNA immobilized on streptavidin beads even in the absence of nucleotide analogs ( Figure 6A , lanes 4 and 5) (44) . On measuring the affinity of Dhh1 for a U 15 RNA by fluorescence anisotropy, we found a Kd in the low micromolar range (Supplementary Figure S4A) , lower than that previously reported for a full-length Dhh1 fusion protein (44) , and lower than that measured for Pat1 and Edc3 using ITC ( Figure 1D and Supplementary Figure S1 ). In the presence of either Pat1 5-79 , or Edc3 77-158 , Dhh1 failed to bind to RNA in the pull-down assay ( Figure 6A , lanes 6,7 and lanes 8,9, respectively), suggesting that they interfere with RNA binding.
Intrigued by the observation that there was no significant difference in the RNA pull-down assays in the presence or absence of ATP, we analyzed the nucleotide-binding properties of Dhh1. First, inspection of the crystal structure of apo Dhh1 (45) indicated that its closed conformation is incompatible with ATP binding (Supplementary Figure S4B) . Dhh1 30-425 indeed did not bind ATP in ITC experiments (Supplementary Figure S4C) and appeared to be essentially inactive in RNA-dependent ATPase assays (Supplementary Figure S4D) , suggesting that Dhh1 is in an enzymatically inactive conformation.
To map how this unusual DEAD-box protein can bind RNA in the absence of ATP, we crosslinked Dhh1 to a U 15 RNA by subjecting the complex to UV irradiation at 254 nm. We then used LC-MS/MS mass spectrometry to detect and sequence peptides conjugated to the mass of an RNA nucleotide [reviewed in (53) ]. Using this approach, we identified 6 tryptic peptides mapping to the RecA2 domain of Dhh1 ( Figure 6B and Supplementary Figure S5) . No peptide was detected in the RecA1 domain, suggesting that this domain is not able to bind RNA when Dhh1 is in the enzymatically inactive conformation. However, the flexible N-terminal region that precedes RecA1 might contribute to RNA binding, as we detected an additional peptide encompassing residues 32-44 (Supplementary Figure S5) . Within RecA2, two peptides mapped to the canonical RNA-binding surface expected for the active state of the DEAD-box protein (red and magenta patches in Figure 6B ). Others mapped to the outer surface of RecA2 (green and yellow patches in Figure 6B ), corresponding to the patch 1 and patch 3 sites. The mass spectrometry analysis identified a direct crosslink between a uridine nucleotide and Cys273 ( Figure 6C ), a residue in a central position at the FDF-binding site on patch 1 ( Figure  3A, central panel) . Consistently, the electrostatic properties of the RecA2 surface show patches of positive charges along the RNA-binding surface mapped by mass-spectrometry ( Figure 6D ). These data indicate that Dhh1 binds Pat1, Edc3 and RNA with mutually exclusive interactions at patch 1 and patch 3.
CONCLUSIONS
Dhh1 has a prominent pocket on the C-terminal RecA2 domain that recognizes short FDF linear motifs present in both yeast Pat1 and Edc3. In the case of the human orthologues, this pocket recognizes either the FDF motif of Edc3 (35) or a DW motif in Pat1b. It is possible that Dhh1 might bind other factors at this pocket, not necessarily with a FDF motif in their sequence. A hydrophobic pocket is present at the corresponding position in human eIF4AIII, where it is used to bind a Tyr-containing short linear motif of Upf3b (58) . An analogous pocket is also present in yeast eIF4A and is used to bind a Trp-containing short linear motif of eIF4G (59) . Other DEAD-box proteins might have evolved this structural feature to recruit short motifs present in their binding factors. While such hydrophobic pocket probably contributes binding affinity, specificity is likely provided by binding to additional surfaces. We note that binding of Pat1 or Edc3 leaves a considerable surface area of Dhh1 unoccupied and potentially available to other binding partners.
Because of their overlapping binding sites, Pat1 and Edc3 cannot bind simultaneously on Dhh1. In addition, they interfere with the RNA-binding properties of Dhh1. Mapping the RNA-binding surfaces of Dhh1 by a crosslinking-mass spectrometry approach suggests that RNA wraps around the RecA2 domain, docking also at the FDF-binding site of Dhh1 (at patch 1). In this conformation, in the absence of ATP, Dhh1 is in an enzymatically inactive state. The presence of both ATP and RNA appears to be insufficient to release the inactive conformation of Dhh1 that arises from the stabilization of an unproductive conformation of the two RecA Figure S5) . On the right, surface representation of apo Dhh1 (45) (in light blue) with the RNA-crosslinked peptides shown in the same colors as on the right. Shown in black is the RNA modeled after superposition with eIF4AIII-AMPNP-RNA in EJC structure upon superposition of the RecA2 domains (54, 55) . Notice that, in this conformation of Dhh1, an RNA bound in the typical ATP-dependent conformation would sterically clash against the domains by an extensive network of intramolecular interactions (44, 45) . Pat1 and in yeast Edc3 are expected also to approach the canonical ATP-dependent RNA-binding surface (at patch 3) with a negatively charged segment, and thus to interfere with it.
The results predict that Pat1, Edc3 and RNA bind Dhh1 as separate steps in the pathway, pointing to the presence of transitions in the architecture of an mRNP as it gets targeted to decay. A working model for the sequence and coordination of these structural rearrangements is outlined below. In the cytoplasm, Dhh1 is present in large excess and binds mRNAs in a constitutive, ATPindependent manner (39, 44, 45) . We envision that upon triggering translational repression and deadenylation, Pat1 and Edc3 binding to Dhh1 would release it from the nonproductive ATP-independent mode of RNA binding. This displacement would allow Dhh1 to bind RNA in a productive ATP-dependent manner, triggering ATP hydrolysis and dissociation from the mRNP. This step is likely to require the binding of an activator to release Dhh1 from the enzymatically inhibited conformation. Besides the Dhh1-binding domain, Pat1 and Edc3 bridge to the Lsm complex and to the decapping complex, respectively. Discovering the precise sequel of events that lead to the swap between Pat1-containing and Edc3-containing complexes on Dhh1 as well as the identity of the Dhh1 activator are quests for future studies.
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